PharmaBoardroom

Mexico Looks to India to Bolster Domestic Supply Chain post-COVID

COVID-19 has highlighted the importance of secure regional pharma supply chains across the globe, not least in Mexico where the state of Hidalgo has…

Stephen Farr – President & CEO, Zogenix

Zogenix’s Dr Stephen Farr shares his remarkable career journey from academia to industry, the company’s transition from pain therapeutics into…

Renée C. Amundsen – Global Head of Business Innovation,…

Merck Healthcare’s newly appointed Global Head of Business innovation, Renée C. Amundsen, highlights the numerous opportunities for change…

Brent Ragans – President, Ferring Pharmaceuticals US

Brent Ragans of Ferring Pharmaceuticals US discusses the effects of the COVID-19 pandemic on the company’s operations, their footprint in…

Cell & Gene Therapy: Command? Consent? Collaborate!

Novartis Oncology’s Emanuele Ostuni (lead author) and Karin Blumer draw on their experience commercialising CAR-T therapies to make the case for the…

Essential Tips for Taking on a New Role in Pharma During a…

COVID-19 has necessitated enormous shifts in the way we live, work, and communicate with each other. Nowhere is this more apparent professionally than…

Mads Stoustrup – VP & General Manager, Novo Nordisk…

Novo Nordisk Switzerland’s Mads Stoustrup introduces the affiliate’s remarkable process on bringing innovative diabetes and obesity treatments to…

Henrik Asmussen – General Manager, Amgen Switzerland

In a wide-ranging interview, Henrik Asmussen outlines his priorities for Amgen’s important Swiss affiliate, market access and pricing challenges,…

France: Mid-2021 for Sanofi COVID-19 Vaccine; 1 Million Domestic…

A roundup of the latest stories from French pharma, including the progress of Sanofi’s COVID-19 vaccine, how Ipsen has managed to achieve sales…

Moving the Needle on Gender Diversity in Swiss Pharma Leadership

While Switzerland has Europe's second-highest proportion of women in the workforce, it trails global standards on gender diversity in boardrooms and…

Utilising Data-Science to Boost US Market Access in Volatile…

Dr Philipp Diesinger and Dr Gabriell Máté outline why a data-driven approach can help optimise patient copay assistance programs in the US across a…

Ramona Sequeira – President, Takeda Pharmaceuticals USA;…

Takeda USA’s Ramona Sequeira outlines her expanded role as president of global portfolio commercialization, the crucial importance of investing in…

Tagged with